DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES Stock

Certificat

DE000ME9G2N5

Real-time Bid/Ask 03:39:08 2024-05-20 am EDT
0.037 EUR / 0.046 EUR +5.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES
Current month-13.04%
1 month-9.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 0.04 0.00%
24-05-16 0.04 0.00%
24-05-15 0.04 -2.44%
24-05-14 0.041 -2.38%
24-05-13 0.042 0.00%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 02:13 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME9G2N
ISINDE000ME9G2N5
Date issued 2024-03-01
Strike 150 $
Maturity 2024-12-20 (215 Days)
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.118
Lowest since issue 0.034
Spread 0.011
Spread %23.40%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW